RINT1 (RAD50 interactor 1) is a novel Rad50-interacting protein with a molecular mass of 87kDa. It comprises of an N-terminal coiled-coil domain, a conserved central domain, and a C-terminal domain.
Synonyms: Anti-HsRINT-1; Anti-Protein RINT-1; Anti-RAD50 interactor 1; Anti-RAD50-interacting protein 1
MDL Number: MFCD03455929
Storage: -20C
Application: All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project (www.proteinatlas.org)and as a result, are supported by the most extensive characterization in the industry. The Human Protein Atlas project can be subdivided into three efforts: Human Tissue Atlas, Cancer Atlas, and Human Cell Atlas. The antibodies that have been generated in support of the Tissue and Cancer Atlas projects have been tested by immunohistochemistry against hundreds of normal and disease tissues and through the recent efforts of the Human Cell Atlas project, many have been characterized by immunofluorescence to map the human proteome not only at the tissue level but now at the subcellular level. These images and the collection of this vast data set can be viewed on the Human Protein Atlas (HPA) site by clicking on the Image Gallery link. To view these protocols and other useful information about Prestige Antibodies and the HPA, visit sigma.com/prestige.
Biochem Physiol Actions: RINT1 (RAD50 interactor 1) is mainly involved in the regulation of telomere lengthening via Rb/E2F pathway. In control of telomere length, it forms a complex with p130 (a nucleolar phosphoprotein) and Rad50, which restricts telomerase-independent telomere lengthening in normal cells. The conserved central and C-terminal domains of RINT1 directly interact with Rad50 during late S and G2/M phases of cell cycle. It has been suggested that RINT1 may be involved in the DNA damage repair via regulating cell cycle progression.
Legal Information: Prestige Antibodies is a registered trademark of Sigma-Aldrich Co. LLC